using four to five biopsy samples was approximately 50%. The highest sensitivity achieved was 79% with 17 biopsy samples obtained. ' Because these studies (biopsy, viral culture, and serology) appear to definitively identify only a portion of patients with myocarditis, additional methods have been sought to improve the diagnostic accuracy in cases of suspected myocarditis. Initially, molecular in situ hybridization studies were performed to evaluate the existence of enteroviral RNA in cardiac tissue. Bowles et al and others3-8 successfully demonstrated viral genome in as many as 50% of cases of myocarditis and idiopathic dilated cardiomyopathy, the latter being considered to possibly be the result of a prior subclinical case of myocarditis. [9] [10] [11] More recently, polymerase chain reaction (PCR), which has been shown to rapidly detect the presence of viral nucleic acid in a variety of infected tissues and body fluids,12-'9 has been used in an attempt to better evaluate the presence of enterovirus in cardiac tissue from patients with myocarditis and dilated cardiomyopathy.20-" This process of PCR can rapidly amplify a desired nucleic acid sequence (in this case, viral sequence) up to 1 billion times in less than 1 day. The basic PCR cycle consists of three steps including heat denaturation, primer annealing, and primer extension. The amplified product can then be visualized on a gel or autoradiograph.
The purposes of this study were to analyze the usefulness of PCR in the rapid diagnosis of acute myocarditis in children and to evaluate multiple viruses as possible etiological agents. 
Methods

Study Design
Prospective and retrospective analyses of 51 patients presenting with acute cardiomyopathy at Texas Children's Hospital, Houston (n=33), Children's Hospital of Pittsburgh (n= 12), and Mount Sinai Medical Center, New York (n=6), were performed. After obtaining informed consent, history, physical examination, and echocardiograms were completed before collecting blood and myocardial samples. The cardiac tissue was obtained either from right ventricular endomyocardial biopsy (RVEMB), autopsy, or from explanted hearts at the time of transplantation. Autopsy samples were either fresh frozen or formalin fixed. The histopathological diagnosis of myocarditis was based on the "Dallas criteria,"29 as outlined in Table 1 . All samples were analyzed by PCR for presence of adenovirus, cytomegalovirus (CMV), enterovirus, and herpes simplex virus (HSV) nucleic acid using presynthesized primers (Table 2) based on the published viral sequences.1347,21,30 Blood, urine, cerebrospinal fluid, and nasopharyngeal viral cultures were obtained when possible (Table 3) , and four cell lines were inoculated (HFF, A549, RhM, and Hep2) and examined daily for 21 days for cytopathic effect. Serological studies, including neutralization tests (enterovirus), complement-fixation tests (adenovirus, CMV), and enzyme-linked immunoabsorbant (ELISA) assays (CMV, HSV) as well as myocardial viral cultures were performed selectively using the same cell lines. Positive serology was defined as a "high" titer for an acute serology (ie, greater than 2 SD above the mean) or a fourfold titer rise when paired serologies were obtained.
Patient Population
All patients presenting with a clinical picture or hospital course consistent with the diagnosis of acute cardiomyopathy or myocarditis from 1978 to 1992, in whom cardiac tissue and histological diagnosis were available, were analyzed. Thirtyfour patients met this initial inclusion criteria, with the ages ranging from 1 day (37 weeks' gestation) to 19 years, with a median age of 2.5 years ( Table 3 ). The diagnostic criteria included clinical presentation consistent with myocarditis and echocardiographic findings of left ventricular dilation and dysfunction with fractional shortening 520%. Patients with the following disorders, which could mimic myocarditis, were excluded from evaluation: endotoxic shock, Kawasaki disease, anomalous left coronary from pulmonary artery, critical aortic stenosis of the newborn, tachyarrhythmias, and cardiomyopathy caused by antineoplastic therapy.
Initial presenting symptoms included acute cardiovascular collapse, acute congestive heart failure, or new-onset respiratory distress; only 3 of the 34 patients did not have a clear history of preceding viral illness (patients 9, 19a, 22; Table 3 ). All nontransplant patients had onset of symptoms within 2 weeks of biopsy or autopsy; the 4 children receiving transplants had onset of symptoms less than 4 weeks before explant. Seventeen control patients included 14 children with congenital heart disease and 3 with hypertrophic cardiomyopathy (Table 4) .
Patient Samples
Thirty-eight myocardial samples were obtained from the 34 patients with acute cardiomyopathy. Sample sources included Table 3 .
Control Samples
Seventeen samples were collected from 17 patients undergoing cardiac transplantation (14) or autopsy (3) . These patients included 14 
Results
Clinical Presentation/Course
All patients presented with either acute cardiovascular collapse, new-onset congestive heart failure, or respiratory distress (Table 3) in conjunction with either echocardiographic evidence of cardiomyopathy or autopsy evidence of myocarditis or cardiomyopathy.
The overall prognosis of the 34 patients with acute cardiomyopathy was poor, with an overall mortality of 62% (21 of 34) ( Table 5 ). Four patients underwent successful orthotopic cardiac transplantation, with two subsequent deaths; 1 of these patients died 2 months after transplantation from disseminated CMV infection. (1) and included 2 with coxsackie B, 1 with echovirus, and 2 nontyped. The positive adenoviral cultures were obtained from nasopharynx; the CMVpositive culture was obtained from urine. One of 18 patients had positive postmortem viral cultures from the heart itself. This patient had postmortem positive cultures for enterovirus from the brain, liver, and kidney (patient 6b, Table 3 ). Another child (patient 25, (Figs 2 and 3 ), 2 amplified HSV type 2 (Fig  4) , and 1 amplified CMV (Fig 5) . When 
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No present in all cells,3' amplification of the 135-bp sequence provided evidence that the PCR-negative samples were true-negative results (Fig 6) .
Correlation Between Histopathology and PCR There was no direct correlation between positive histopathology and positive PCR analysis (Fig 7) . Nineteen of the 38 samples analyzed had conflicting pathology and PCR results (50%), with 13 samples having negative histopathology with positive PCR analysis. Twelve out of 38 samples had both positive PCR and positive histopathology. Analysis of the 15 samples that amplified adenovirus revealed that 10 of these did not fulfill histopathological criteria for myocarditis (ie, 67% correlation). Seven of the 8 samples that amplified enterovirus (ie, 88% correlation), however, were consistent with myocarditis using the Dallas criteria.
Discussion
The definitive diagnosis of viral myocarditis has remained elusive. A pathognomonic clinical syndrome is not seen, and vague symptoms of antecedent viral Table 2 ) had severe dilated cardiomyopathy and was transplanted but later died from overwhelming cytomegalovirus disease. Note the absence of a 241-bp HSV2 (herpest simplex virus) band. Pax RVEMB (patient 5, Table  3 ) died of congestive heart failure while awaiting transplant. Amplification of the 241 -bp band is seen (last lane) and is similar to the HSV-positive control. The HSV-negative control is devoid of PCR product, as expected. EN, ES, and MCI are right ventricular endomyocardial biopsy (RVEMB) samples from patients with histories consistent with myocarditis; all are negative for HSV sequence amplification. HSV negative control is PCR reaction with no template DNA. In summary, PCR offers a rapid, sensitive way to diagnose the presence of viral nucleic acid from the heart itself. When used in conjunction with standard endomyocardial biopsy, it appears to improve the accuracy/sensitivity of the diagnosis of viral myocarditis.
We speculate that the epidemiology of myocarditis is less understood than previously described. Adenoviruses (and possibly others not evaluated) are likely to play a major role in the pathogenesis of myocarditis. The role of our current diagnostic gold standards for myocarditis, peripheral culture, and histology will need to be reevaluated. Our basic concepts of myocarditis are evolving, but additional information concerning the agents involved in this disorder and the mechanism of action leading to disease must be uncovered before definitive understanding is gained.
